Hikma Pharmaceuticals (HKMPY) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Hikma Pharmaceuticals

    OTC: HKMPY · Real-Time Price · USD
    49.25
    -0.15 (-0.30%)
    At close: Oct 03, 2025, 12:19 PM
    49.25
    0.00%
    Pre-market: Oct 03, 2025, 09:44 AM EDT

    Hikma Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2025 Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Revenue
    		 1.66B 1.56B 1.57B 1.44B 1.43B 1.37B 1.21B 1.35B 1.22B
    Cost of Revenue
    		 933M 899M 813M 813.48M 737M 745.81M 633M 718.63M 629M
    Gross Profit
    		 725M 609.8M 756M 623.01M 690M 622.03M 580M 630.82M 587M
    Operating Income
    		 259M 234.61M 351M 125M 348M 263.29M 255M 303.8M 296M
    Interest Income
    		 4.03M 3.96M 4M 3.97M 3M 2.1M 1M 18M 1M
    Pretax Income
    		 295M 167M 288M 78.37M 202M 18.88M 215M 226.08M 319M
    Net Income
    		 238M 131.66M 226M 58.53M 131M 15.73M 173M 174.61M 248M
    Selling & General & Admin
    		 278M 295.99M 280M 414.68M 260M 280.07M 256M 242.23M 232M
    Research & Development
    		 73M 79.19M 61M 84.32M 64M 78.67M 69M 84.78M 59M
    Other Expenses
    		 115M 22.81M 64M -992.05K -18M n/a n/a n/a n/a
    Operating Expenses
    		 466M 398M 405M 498.01M 342M 358.74M 325M 327.01M 291M
    Interest Expense
    		 40.34M 43.56M 44M 42.66M 44M 46.15M 33M 31.29M 25M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 1.4B 1.3B 1.22B 1.31B 1.08B 1.1B 958M 1.05B 920M
    Income Tax Expense
    		 55M 33.66M 59M 17.86M 71M 1.05M 41M 53.49M 71M
    Shares Outstanding (Basic)
    		 111.21M 110.32M 111.88M 111.37M 111.02M 110.23M 113.97M 116.98M 116M
    Shares Outstanding (Diluted)
    		 111.21M 111.52M 111.88M 111.37M 111.02M 110.91M 114M 117M 116M
    EPS (Basic)
    		 2.16 1.20 2.04 0.54 1.18 0.14 1.52 1.48 2.14
    EPS (Diluted)
    		 2.14 1.18 2.02 0.52 1.18 0.14 1.52 1.48 2.14
    EBITDA
    		 476M 308.86M 427M 214.28M 446M 284M 341M 347.2M 422M
    EBIT
    		 374M 208.88M 331M 120.04M 309M 65.04M 248M 257.37M 344M
    Depreciation & Amortization
    		 102M 99.98M 96M 94.25M 96M 101.75M 93M 89.83M 78M

    Add to Watchlist